2019, ' Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer : the prospective Streamline C trial ', The Lancet Gastroenterology & Hepatology, vol. 4, no. 7, pp. 529-537 . https://doi.org/10.1016/S2468-1253(19)30056-1 The Lancet. Gastroenterology & Hepatology
Taylor, S A, Mallett, S, Ball, S, Beare, S, Bhatnagar, G, Bhowmik, A, Boavida, P, Bridgewater, J, Clarke, C S, Duggan, M, Ellis, S, Glynne-Jones, R, Goh, V, Groves, A M, Hameeduddin, A, Janes, S M, Johnston, E W, Koh, D M, Lock, S, Miles, A, Morris, S, Morton, A, Navani, N, Oliver, A, O'Shaughnessy, T, Padhani, A R, Prezzi, D, Punwani, S, Quinn, L, Rafiee, H, Reczko, K, Rockall, A G, Russell, P, Sidhu, H S, Strickland, N, Tarver, K, Teague, J, Halligan, S, Evans, R, Shahabuddin, K, Jannapureddy, R, Mills-Baldock, T, Barhate, K, Nagy, Z, Raouf, S, Rich, N, Loke, T K, Gourtsoyianni, S & Kelly-Morland, C & Jalloh, A 2019, ' Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer : the prospective Streamline L trial ', The Lancet Respiratory Medicine, vol. 7, no. 6, pp. 523-532 . https://doi.org/10.1016/S2213-2600(19)30090-6